Survivin Ser81 Plays An Important Role in PI3K/Akt/mTOR Signaling Pathway
Abstract
Background: Survivin, a member of the inhibitor of apoptosis protein family, has been associated with protection from cell apoptosis and regulation of mitosis. Phosphorylated-Survivin at Ser81 was reported to provide cytoprotection against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in L929 cells by inducing a backloop activation of phosphatidylinositol 3-kinase (PI3K). Therefore Akt as a possible substrate of PI3K was investigated.
Methods: L929 cells were pretreated with/without 50 μM LY294002 or 10 μM Perifosine, and infected with viral particle of Survivin, anti sense of Survivin, Ser81Ala mutated Survivin or vector only. Cells were then harvested, lysed and subjected to immunoblot assay to detect Akt, phosphorylated Akt (Ser473), mammalian target of rapamycin (mTOR), phosphorylated-mTOR (Ser2448).
Results: Survivin induced Akt and mTOR phosphorylations in a viral particle concentration dependent manner. Pretreatment of LY294002 or Perifosine prior to Survivin infection, attenuated Akt or mTOR phosphorylations, respectively. Low Akt or mTOR phosphorylations were observed when L929 cells were infected with Ser81Ala mutated Survivin.
Conclusion: Ser81 phosphorylation site of Survivin played an important role in activating Survivin/PKA/PI3K/Akt/mTOR signaling pathway.
Keywords: survivin, Ser81, Akt, mTOR, LY294002, perifosine
Full Text:
PDFReferences
Athanasoula KCh, Gogas H, Polonifi K, Vaiopoulos AG, Polyzos A, Mantzourani M. Survivin Beyond Physiology: Orchestration of Multistep Carcinogenesis and Therapeutic Potentials. Cancer Lett. 2014; 347(2): 175-82, CrossRef.
Altieri DC. Survivin - The inconvenient IAP. Semin Cell Dev Biol. 2015; 39: 91-6, CrossRef.
Sandra F, Khosravi-Far R. Phosphorylated-survivin at Ser81 Induced Protein Kinase A (PKA): A Back Loop. Indones Biomed J. 2011; 3(2): 138-42, CrossRef.
Fernández JG, Rodríguez DA, Valenzuela M, Calderon C, Urzúa U, Munroe D, et al. Survivin Expression Promotes VEGF-induced Tumor Angiogenesis via PI3K/Akt Enhanced β-catenin/Tcf-Lef Dependent Transcription. Mol Cancer. 2014; 13: 209, CrossRef.
Sanhueza C, Wehinger S, Castillo Bennett J, Valenzuela M, Owen GI, Quest AF. The Twisted Survivin Connection To angiogenesis. Mol Cancer. 2015; 14: 198, CrossRef.
Zhou S, Li L, Jian X, Ou X, Jiang H, Yao Z, et al. The Phosphorylation of Survivin Thr34 by p34cdc2 in Carcinogenesis of Oral Submucous Fibrosis. Oncol Rep. 2008; 20(5): 1085-91, PMID.
Sandra F, Khosravi-Far R. Survivin S81A Enhanced TRAIL's Activity in Inducing Apoptosis. Indones Biomed J. 2010; 2(3): 113-7, CrossRef.
Sandra F, Khosravi-Far R. Ser81 Survivin Induced Protein Kinase A (PKA)-dependent Phosphatidylinositol 3-Kinase (PI3K) Activity. Indones Biomed J. 2014; 6(3): 157-62, CrossRef.
Qiu Y, Li X, Yi Bin, Zheng J, Peng Z, Zhang Z, et al. Protein Phosphatase PHLPP Induces Cell Apoptosis and Exerts Anticancer Activity by Inhibiting Survivin Phosphorylation and Nuclear Export in Gallbladder Cancer. Oncotarget. 2015; 6(22): 19148-62, CrossRef.
Ma WH, Liu YC, Xue ML, Zheng Z, Ge YL. Downregulation of Survivin Expression Exerts Antitumoral Effects on Mouse Breast Cancer Cells in vitro and in vivo. Oncol Lett. 2016; 11(1): 159-167, CrossRef.
Pannone G, Bufo P, Serpico R, Rubini C, Zamparese R, Corsi F, et al. Survivin Phosphorylation and M-phase Promoting Factor in Oral Carcinogenesis. Histol Histopathol. 2007; 22(11): 1241-9, PMID.
Delacour-Larose M, Thi MN, Dimitrov S, Molla A. Role of Survivin Phosphorylation by Aurora B in Mitosis. Cell Cycle. 2007; 6(15): 1878-85, CrossRef.
Blanco-Aparicio C, Renner O, Leal JF, Carnero A. PTEN, More Than the AKT Pathway. Carcinogenesis. 2007; 28(7): 1379-86, CrossRef.
Zhang S, Yu D. PI(3)king Apart PTEN's Role in Cancer. Clin Cancer Res. 2010; 16(17): 4325-30, CrossRef.
Lunardi A, Webster KA, Papa A, Padmani B, Clohessy JG, Bronson RT, et al. Role of Aberrant PI3K Pathway Activation in Gallbladder Tumorigenesis. Oncotarget. 2014; 5(4): 894-900, CrossRef.
Chang L, Graham PH, Ni J, Hao J, Bucci J, Cozzi PJ, et al. Targeting PI3K/Akt/mTOR Signaling Pathway in The Treatment of Prostate Cancer Radioresistance. Crit Rev Oncol Hematol. 2015; 96(3): 507-17, CrossRef.
DOI: https://doi.org/10.21705/mcbs.v2i2.2
Copyright (c) 2018 Cell and BioPharmaceutical Institute

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
Cell and BioPharmaceutical Institute